Home › Funds › EVENTIDE ASSET MANAGEMENT, LLC › AXSM

EVENTIDE ASSET MANAGEMENT, LLC position in AXSM

AXSOME THERAPEUTICS INC. · Health Care

EVENTIDE ASSET MANAGEMENT, LLC reported holding 300,102 shares of AXSM (AXSOME THERAPEUTICS INC.) in its Q3 2026 13F filing — a position valued at US$55.3M, representing 0.78% of its reported portfolio and ranking #38 among its reported holdings. EVENTIDE ASSET MANAGEMENT, LLC has disclosed AXSM holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)300.10K sh
Reported value held$55.34M
Portfolio Weight0.78%
First reportedQ3 2023
Last changeReduce
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How EVENTIDE ASSET MANAGEMENT, LLC's AXSM position evolved

EVENTIDE ASSET MANAGEMENT, LLC first disclosed a stake in AXSM in Q3 2023 at 346,712 shares (US$24.2M). The position peaked in Q4 2025 at 571,226 shares, worth US$104.2M. Across 13 filings, EVENTIDE ASSET MANAGEMENT, LLC increased the stake 2 time(s), trimmed it 7 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 300,102 shares valued at US$55.3M — a reduction of -16,718 shares quarter over quarter.. Notable position changes include a 171% increase in Q2 2024 (shares rose 12% over the following quarter), a 39% trim in Q2 2026 (shares fell 25% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 346.71K $24.23M New
Q4 2023 346.71K $27.59M Hold
Q1 2024 346.71K $27.67M Hold
Q2 2024 938.71K $75.57M Add
Q3 2024 827.89K $74.40M Reduce
Q4 2024 828.71K $70.12M Hold
Q1 2025 744.85K $86.88M Reduce
Q2 2025 725.67K $75.75M Reduce
Q3 2025 746.40K $90.64M Add
Q4 2025 571.23K $104.20M Reduce
Q1 2026 519.56K $87.78M Reduce
Q2 2026 316.82K $77.53M Reduce
Q3 2026 300.10K $55.34M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AXSM and 13F data

AXSM (AXSOME THERAPEUTICS INC.) is a Health Care company. 48 other funds we track also report a position in AXSM — the largest reported positions include Deep Track Capital, LP (US$171.3M), ALETHEA CAPITAL MANAGEMENT, LLC (US$119.7M), Hood River Capital Management LLC (US$98.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AXSM

All AXSM fund holders →

FAQ

How long has EVENTIDE ASSET MANAGEMENT, LLC held AXSM?

EVENTIDE ASSET MANAGEMENT, LLC has disclosed AXSM holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is EVENTIDE ASSET MANAGEMENT, LLC's current position in AXSM?

As of Q3 2026, EVENTIDE ASSET MANAGEMENT, LLC holds 300.10K shares of AXSM (AXSOME THERAPEUTICS INC.), valued at $55.34M, representing 0.78% of its reported portfolio and ranking #38.

Has EVENTIDE ASSET MANAGEMENT, LLC been buying or selling AXSM?

In the latest 13F filing (Q3 2026), EVENTIDE ASSET MANAGEMENT, LLC reduced its position in AXSM. The position peaked in Q4 2025 at 571.23K shares.

Which other funds hold AXSM?

Other major institutional holders of AXSM include Deep Track Capital, LP, ALETHEA CAPITAL MANAGEMENT, LLC, Hood River Capital Management LLC, among 48 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.